Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Induction of autophagy via the PI3K/Akt/mTOR signaling pathway by Pueraria flavonoids improves non-alcoholic fatty liver disease in obese mice
Chunbin Sun, Jin Zhang, Jiong Hou, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114005-114005
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth
Zahra Dashti, Zeynab Yousefi, Pouria Kiani, et al.
Metabolism (2024) Vol. 154, pp. 155811-155811
Closed Access | Times Cited: 19
Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1166-1166
Open Access | Times Cited: 23
Pharmacological Activity of Flavonoid Quercetin and Its Therapeutic Potential in Testicular Injury
Xiaohui Zhang, Yufeng Tang, Guangping Lu, et al.
Nutrients (2023) Vol. 15, Iss. 9, pp. 2231-2231
Open Access | Times Cited: 21
Mechanistic Action of Cell Cycle Arrest and Intrinsic Apoptosis via Inhibiting Akt/mTOR and Activation of p38-MAPK Signaling Pathways in Hep3B Liver Cancer Cells by Prunetrin—A Flavonoid with Therapeutic Potential
Abuyaseer Abusaliya, Se Hyo Jeong, Pritam Bhagwan Bhosale, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3407-3407
Open Access | Times Cited: 19
Natural Activators of Autophagy
Julia A. Pavlova, Ekaterina A. Guseva, О. А. Донцова, et al.
Biochemistry (Moscow) (2024) Vol. 89, Iss. 1, pp. 1-26
Closed Access | Times Cited: 7
Total flavonoids of Broussonetia papyrifera alleviate non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signaling pathways
Qi Wang, Yunfei Wei, Yeling Wang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2024) Vol. 1869, Iss. 5, pp. 159497-159497
Closed Access | Times Cited: 7
Pueraria lobata antioxidant extract ameliorates non-alcoholic fatty liver by altering hepatic fat accumulation and oxidative stress
Hongying Dong, Yu Zhao, He Teng, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118468-118468
Closed Access | Times Cited: 6
Exploring the mechanism of Pueraria lobata (Willd.) Ohwi in the regulation of obesity
Jingxin Mao, Maolin Li, Xiaodong Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 335, pp. 118703-118703
Closed Access | Times Cited: 6
Gualou-Xiebai herb pair and its active ingredients act against atherosclerosis by suppressing VSMC-derived foam cell formation via regulating P2RY12-mediated lipophagy
Youli Bao, Li Zhu, Yuting Wang, et al.
Phytomedicine (2024) Vol. 128, pp. 155341-155341
Closed Access | Times Cited: 5
Structural insights and biological activities of flavonoids: Implications for novel applications
Sheng Tang, Botao Wang, Xin Liu, et al.
Food Frontiers (2024)
Open Access | Times Cited: 5
Puerariae Lobatae Radix: Progress in Extraction, Separation, and Pharmacological Activities Research
E.J. Gao, Wei Wang, Yuanyuan Huang, et al.
Separations (2024) Vol. 11, Iss. 7, pp. 195-195
Open Access | Times Cited: 4
β-Carotene-loaded cationic nanoparticles ameliorate MASLD via modulating lipid homeostasis and gut microbiome
Lan‐Feng Dong, Wen‐Yong Lou, Juan Wang
Food Research International (2025) Vol. 205, pp. 115816-115816
Closed Access
Herbal medicine as a potential treatment for non-alcoholic fatty liver disease
Wenyi Nie, Ye Yang, Hongxuan Tong, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 9
Closed Access
Puerarin Targets HIF-1α to Modulate Hypoxia-Related Sphingolipid Metabolism in Diabetic Hepatopathy via the SPTLC2/Ceramide Pathway
Meng‐Ting Cai, Wei Lai, Huien Chen, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 398-398
Open Access
Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
Toru Nakamura, Atsutaka Masuda, Dan Nakano, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 428-428
Open Access
Pueraria Radix and Its Major Constituents Against Metabolic Diseases: Pharmacological Mechanisms and Potential Applications
Lei Yan, Ruiyuan Zhang, Yan Li, et al.
Phytotherapy Research (2025)
Closed Access
Resveratrol and N-acetylcystein reduce hepatic steatosis but enhance initiation and progression of hepatocellular carcinoma by inhibiting GST-pi-MAPK axis in mice
Mi Zhang, Weigang Yuan, Chun Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Pueraria: A Comprehensive Review of Chemical Composition, Health Benefits, and Current Applications
Qiong Wu, Kai Chen, Yaru Li, et al.
Comprehensive Reviews in Food Science and Food Safety (2025) Vol. 24, Iss. 3
Closed Access
Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis
Anna Kakehashi, Shugo Suzuki, Hideki Wanibuchi
Cancers (2023) Vol. 15, Iss. 18, pp. 4566-4566
Open Access | Times Cited: 9
Research Progress of Chinese Medicine in Treating Chronic Liver Disease by Regulating Autophagy
Shihao Zheng, Chengyuan Xue, Tianyu Xue, et al.
The American Journal of Chinese Medicine (2024), pp. 1-25
Closed Access | Times Cited: 2
Exercise against nonalcoholic fatty liver disease: Possible role and mechanism of lipophagy
Pei Su, Jiangang Chen, Donghui Tang
Life Sciences (2023) Vol. 327, pp. 121837-121837
Closed Access | Times Cited: 6
LIPUS combined with TFSC alleviates premature ovarian failure by promoting autophagy and inhibiting apoptosis
Weimei Zhou, Aixue Chen, Yongju Ye, et al.
Gynecological Endocrinology (2023) Vol. 39, Iss. 1
Open Access | Times Cited: 6
Network pharmacological analysis on the mechanism of Linggui Zhugan decoction for nonalcoholic fatty liver disease
Songlin Gao, Liuting Wei, Yan Qin, et al.
Medicine (2024) Vol. 103, Iss. 10, pp. e37281-e37281
Open Access | Times Cited: 2
Emerging role of natural lipophagy modulators in metabolic dysfunction–associated steatotic liver disease
Nahla E. El‐Ashmawy, Eman M. Khedr, Ghada M. Al‐Ashmawy, et al.
Nutrition (2024) Vol. 126, pp. 112517-112517
Closed Access | Times Cited: 2
The essential effect of mTORC1-dependent lipophagy in non-alcoholic fatty liver disease
Xiangyun Tan, Xinyu Huang, Zhuhang Lu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top